Connect Biopharma Holdings Limited Earnings Per Share (Basic)
Connect Biopharma Holdings Limited (CNTB) reported Earnings Per Share (Basic) of -$0.27 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- Connect Biopharma Holdings Limited earnings per share, basic for the quarter ending 2026-06-30 was -$0.27.
- Connect Biopharma Holdings Limited earnings per share, basic for the quarter ending 2026-03-31 was -$0.34.
- Connect Biopharma Holdings Limited earnings per share, basic for the quarter ending 2025-12-31 was -$0.27.
- Connect Biopharma Holdings Limited earnings per share, basic for the quarter ending 2025-09-30 was -$0.31.
- Connect Biopharma Holdings Limited earnings per share, basic for fiscal 2025 was -$1.00.
- Connect Biopharma Holdings Limited earnings per share, basic for fiscal 2024 was -$0.28.
- Connect Biopharma Holdings Limited earnings per share, basic for fiscal 2023 was -$1.13.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.27 10-Q · filed 2026-08-12 | -$0.61 10-Q · filed 2026-08-12 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2026-03-31 | -$0.34 10-Q · filed 2026-05-12 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.15 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-12-31 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.00 10-K · filed 2026-03-31 |
| 2025-09-30 | -$0.31 10-Q · filed 2025-11-12 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.73 10-Q · filed 2025-11-12 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-06-30 | -$0.23 10-Q · filed 2026-08-12 | -$0.42 10-Q · filed 2026-08-12 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-03-31 | -$0.19 10-Q · filed 2026-05-12 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2024-12-31 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.28 10-K · filed 2026-03-31 |
| 2024-09-30 | -$0.23 10-Q · filed 2025-11-12 | $0.04 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.12 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $0.27 10-Q · filed 2025-08-13 | $0.11 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$0.16 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$1.13 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |